Discounted Cash Flow Rating

Return on Equity Rating

Debt to Equity Rating

Price to Earnings Rating

Analyst Rating

()

No description provided.

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

01/01/1970

Market Cap

N/A

Shares Outstanding

N/A

Weighted SO

N/A

Total Employees

N/A

Upcoming Earnings

N/A

Similar Tickers

Beta

N/A

Last Div

N/A

Range

N/A

Chg

N/A

Avg Vol

N/A

Mkt Cap

N/A

Exch

N/A

Country

N/A

Phone

N/A

DCF Diff

N/A

DCF

N/A

Div Yield

N/A

P/S

N/A

EV Multiple

N/A

P/FV

N/A

Div Yield %

N/A

P/E

N/A

PEG

N/A

Payout

N/A

Current Ratio

N/A

Quick Ratio

N/A

Cash Ratio

N/A

DSO

N/A

DIO

N/A

Op Cycle

N/A

DPO

N/A

CCC

N/A

Gross Margin

N/A

Op Margin

N/A

Pretax Margin

N/A

Net Margin

N/A

Eff Tax Rate

N/A

ROA

N/A

ROE

N/A

ROCE

N/A

NI/EBT

N/A

EBT/EBIT

N/A

EBIT/Rev

N/A

Debt Ratio

N/A

D/E

N/A

LT Debt/Cap

N/A

Total Debt/Cap

N/A

Int Coverage

N/A

CF/Debt

N/A

Equity Multi

N/A

Rec Turnover

N/A

Pay Turnover

N/A

Inv Turnover

N/A

FA Turnover

N/A

Asset Turnover

N/A

OCF/Share

N/A

FCF/Share

N/A

Cash/Share

N/A

OCF/Sales

N/A

FCF/OCF

N/A

CF Coverage

N/A

ST Coverage

N/A

CapEx Coverage

N/A

Div&CapEx Cov

N/A

P/BV

N/A

P/B

N/A

P/S

N/A

P/E

N/A

P/FCF

N/A

P/OCF

N/A

P/CF

N/A

PEG

N/A

P/S

N/A

EV Multiple

N/A

P/FV

N/A

DPS

N/A

Latest Headlines (EST)

GlobeNewswire Inc. Jul 10, 23:05 Vera Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) GlobeNewswire Inc. May 08, 22:45 Vertex to Present at 20th Annual Needham Technology, Media, & Consumer Conference The Motley Fool Apr 18, 22:36 Why Verve Therapeutics Zoomed 40% Higher This Week GlobeNewswire Inc. Dec 09, 23:29 Vera Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) GlobeNewswire Inc. Oct 26, 23:30 Vera Therapeutics Announces 96-week eGFR Stabilization in ORIGIN Phase 2b Study of Atacicept in IgAN in a Late-Breaking Oral Presentation at the American Society of Nephrology Kidney Week 2024 GlobeNewswire Inc. Oct 25, 00:43 VERV DEADLINE NOTICE: ROSEN, A LONGSTANDING LAW FIRM, Encourages Verve Therapeutics, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important October 28 Deadline in Securities Class Action Commenced by the Firm – VERV GlobeNewswire Inc. Oct 24, 05:55 Verkkokauppa.com Oyj: Correction to Stock Exchange Release: Verkkokauppa.com Interim Report for 1 January–30 September 2024 GlobeNewswire Inc. Oct 24, 00:19 Verve Therapeutics, Inc. Investors: Please contact the Portnoy Law Firm to recover your losses. October 28, 2024 Deadline to file Lead Plaintiff Motion GlobeNewswire Inc. Oct 23, 00:11 VERV FINAL DEADLINE: RLF, RECOGNIZED INVESTOR COUNSEL, Encourages Verve Therapeutics, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important October 28 Deadline in Securities Class Action Commenced by the Firm – VERV GlobeNewswire Inc. Oct 19, 15:57 VERV DEADLINE: RLF, THE FIRST FILING FIRM, Encourages Verve Therapeutics, Inc. Investors With Losses in Excess of 100K to Secure Counsel Before Important October 28 Deadline in Securities Class Action Commenced by the Firm – VERV GlobeNewswire Inc. Oct 18, 00:35 Pixalate Releases Q2 2024 APAC Supply-Side Platform (SSP) Market Share Rankings for Mobile Apps & Web: Google AdExchange No. 1 on Web in China (48%) and Japan (46%) GlobeNewswire Inc. Oct 11, 23:45 ROSEN, A LEADING LAW FIRM, Encourages Verve Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action Commenced by the Firm – VERV GlobeNewswire Inc. Sep 28, 13:56 ROSEN, A LEADING NATIONAL FIRM, Encourages Verve Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm – VERV GlobeNewswire Inc. Sep 22, 01:00 Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against WEBTOON, Verve, and Ardelyx and Encourages Investors to Contact the Firm GlobeNewswire Inc. Sep 21, 19:19 ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Verve Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm – VERV GlobeNewswire Inc. Sep 17, 22:31 VERV CLASS ACTION: Verve Therapeutics, Inc. Stockholders Should Contact Robbins LLP for Information About the Securities Class Action Lawsuit GlobeNewswire Inc. Sep 15, 20:00 VERV SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Verve Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! GlobeNewswire Inc. Sep 13, 21:11 ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Verve Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm – VERV GlobeNewswire Inc. Sep 10, 01:00 Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against WEBTOON, Verve, and Ardelyx and Encourages Investors to Contact the Firm GlobeNewswire Inc. Sep 01, 18:56 ????, ????? ????? ??? ??????? ???????, ?????? ?? ?????? Verve Therapeutics, Inc ???? ????? ???? ????? ??? ???? ?????? ??????? ??????? ??? ?????? ??????? ?? ??? ????? – VERV

Revenue Product Segmentation